Discovered a new therapeutic target for the treatment of Alzheimer's disease
The results of the study indicate that the levels of the protein SFRP1 are abnormally elevated in the brain and cerebrospinal fluid of Alzheimer's patients
Alzheimer's disease is characterized by a progressive and irreversible loss of cognitive abilities. "Treatment of the disease represents an unresolved challenge that needs alternative approaches to those currently on trial; there is need of new perspectives that take into account the complexity of the disease. Given its multifactorial origin, these new approaches should be designed against factors that act simultaneously in more than one of the pathological processes of the disease" explains Paola Bovolenta, CSIC researcher at the Molecular Biology Center 'Severo Ochoa' (Joint centre of the CSIC and the Autonomous University of Madrid).
This study identifies that the protein SFRP1 (Secreted Frizzled Related Protein 1) is one of those factors. SFRP1 acts in multiple processes and its elevated levels are pathogenic. "We believe that our results represent an innovation in the field of Alzheimer's disease. We demonstrate that the neutralization of SFRP1 could be a promising therapeutic alternative. This is something that we now need to explore in depth. We also believe that the measure of SFRP1 levels in the cerebrospinal fluid or in serum may represent a useful diagnostic marker in the future, "adds Pilar Esteve, co-responsible of the study and member of the Center for Molecular Biology Severo Ochoa '.
Original publication
Pilar Esteve, Javier Rueda-Carrasco, María Inés Mateo, María Jesús Martin-Bermejo, Jonathan Draffin, Guadalupe Pereyra, África Sandonís, Inmaculada Crespo, Inmaculada Moreno, Ester Aso, Paula Garcia-Esparcia, et al.; "Elevated levels of Secreted-Frizzled-Related- Protein 1 contribute to Alzheimer's disease pathogenesis."; Nature Neuroscience.
Most read news
Original publication
Pilar Esteve, Javier Rueda-Carrasco, María Inés Mateo, María Jesús Martin-Bermejo, Jonathan Draffin, Guadalupe Pereyra, África Sandonís, Inmaculada Crespo, Inmaculada Moreno, Ester Aso, Paula Garcia-Esparcia, et al.; "Elevated levels of Secreted-Frizzled-Related- Protein 1 contribute to Alzheimer's disease pathogenesis."; Nature Neuroscience.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.